Results 211 to 220 of about 1,464,129 (347)
An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials [PDF]
H. N. Harsha Kumar +2 more
openalex +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study). [PDF]
Ito F +18 more
europepmc +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Cancer in a drop: Liquid biopsy highlights from the American Society of Clinical Oncology (ASCO) 2025 annual congress. [PDF]
Martinelli C +9 more
europepmc +1 more source
Big Data and Clinical Research in Oncology: The Good, the Bad, the Challenges, and the Opportunities [PDF]
Christopher M. Pezzi
openalex +1 more source
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié +13 more
wiley +1 more source
Key breast cancer highlights from the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. [PDF]
Venkataraman J, Mokbel K.
europepmc +1 more source

